The potential importance of this finding is shown in prospective cohort studies that found a low level of erythrocyte GPx-1 activity was associated with increased risk of nonfatal myocardial infarction or death from cardiovascular causes in patients with CAD (Espinola-Klein et al. 2007). The gene discussed is GPX1; the disease is myocardial infarction.